Journal article

Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin

Catherine E Winbanks, Kate L Weeks, Rachel E Thomson, Patricio V Sepulveda, Claudia Beyer, Hongwei Qian, Justin L Chen, James M Allen, Graeme I Lancaster, Mark A Febbraio, Craig A Harrison, Julie R McMullen, Jeffrey S Chamberlain, Paul Gregorevic

JOURNAL OF CELL BIOLOGY | ROCKEFELLER UNIV PRESS | Published : 2012

Grants

Awarded by National Health and Medical Research Council (NHMRC; Australia)


Awarded by Muscular Dystrophy Association (USA)


Awarded by National Institutes of Health


Awarded by NHMRC


Awarded by Australian Research Council


Awarded by NATIONAL INSTITUTE ON AGING


Funding Acknowledgements

This work was supported by funding from the National Health and Medical Research Council (NHMRC; Australia) awarded to P. Gregorevic (526648), and C.A. Harrison (1006488), from the Muscular Dystrophy Association (USA) awarded to P. Gregorevic (69684), and funding from the National Institutes of Health (AG033610) awarded to J.S. Chamberlain. M.A. Febbraio is supported by an NHMRC Senior Principal Research Fellowship. C.A. Harrison is supported by a NHMRC Career Development Fellowship (1013533). J.R. McMullen is supported by an Australian Research Council Future Fellowship (FT0001657) and Honorary NHMRC Senior Research Fellowship (586604). P. Gregorevic is supported by a Senior Research Fellowship sponsored by Pfizer Australia. The Baker IDI Heart and Diabetes Institute is supported in part by the Operational Infrastructure Support Program of the Victorian Government.